They further mentioned that SOX9 hampers the transcriptional activation of YAP by disrupting the DNA binding of YAP/TEAD in hepatocytes.17 However, in the present study, we found that SOX9 plays a crucial role in promoting YAP activation and enhancing its oncogenic properties during HCC progression. The gene discussed is SOX9; the disease is hepatocellular carcinoma.